Cell & Gene therapies are too important to have prescriptions impeded by cost. Two Labs develops unique, advanced payer-strategy models that help alleviate payer challenges and increase prescription of C&G treatments. Read more from Two Labs’ Senior Consultant Anne Runyan about how our Cell & Gene payer strategy helps get life-changing therapies to patients who need them: Read more on Pharmaceutical Commerce
COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the launch journey. Today, we spoke with Vice President of PharmaLicense Ryan Fields about the effect of COVID-19 on state licensing. [...]
COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the launch journey. If you’d like to speak with us about how to plan your 3PL inspection process, get in touch. [...]
Virtual Payer Panels and Advisory Boards As the global landscape continues to change with daily COVID-19 developments, it’s vital that manufacturers remain adaptable. Which is why Two Labs is offering innovative ways of doing competitive simulations and seminars, virtual payer panels, and interactive client meetings. Our Market Access team is here to arrange virtual panel discussions, giving your team the chance to discuss challenges and opportunities your [...]
COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the development journey. Let's Talk Posted by: Will Pih EVP of Specialty Commercialization [...]
Our team took a look at the most recent pharmaceutical developments from the week, including where we are with treatment options and how manufacturers are racing to find an effective treatment for COVID-19. COVID-19 has had significant effects across the healthcare system There are several vaccines and drug candidates in development which could help prevent or treat COVID-19 VACCINES* [...]
A message regarding COVID-19 and Ongoing work To Our Community, Like many of you, we’ve had to be flexible and responsive during the past couple of weeks and plan to continue doing so as the COVID-19 pandemic unfolds in the weeks and months ahead. We’re currently working remotely to keep our employees, colleagues, and families safe. Being that we already have a large remote team, the transition [...]
At Two Labs, our mission is to improve patients’ quality of life by delivering innovative trade and commercialization services to pharmaceutical manufacturers. This is why we’re pleased to announce that as of February 3, 2020, Two Labs has acquired CEEK Enterprises, a management consultancy focused on biopharma/med tech with specialized expertise in corporate development, commercial strategy, clinical development and medical affairs. This acquisition strengthens our mission by adding complementary [...]
Originally posted on PR Newswire Two Labs Acquires CEEK Enterprises Company enhances services for biopharma clients with CEEK's complementary suite of management consulting expertise COLUMBUS, Ohio, Feb. 6, 2020 /PRNewswire/ -- Two Labs, an industry-leading pharma services company, today announced that it has acquired CEEK Enterprises, a management consultancy dedicated to supporting clients in the biopharma and MedTech industries with specialized expertise in corporate development, commercial strategy, clinical development [...]
In February of this year, CEEK Enterprises brought to the Two Labs Family a new echelon of specialized expertise in life sciences corporate development, commercial strategy, clinical development and medical affairs. Read more about how the CEEK acquisition added to Two Labs’ support and advancement of pharma product commercialization: Read more on Pharmaceutical Outsourcing Read more on Drug Development & Delivery Read more on Smart Business Columbus Read more on [...]